GB0525897D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0525897D0
GB0525897D0 GB0525897A GB0525897A GB0525897D0 GB 0525897 D0 GB0525897 D0 GB 0525897D0 GB 0525897 A GB0525897 A GB 0525897A GB 0525897 A GB0525897 A GB 0525897A GB 0525897 D0 GB0525897 D0 GB 0525897D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0525897A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0525897A priority Critical patent/GB0525897D0/en
Publication of GB0525897D0 publication Critical patent/GB0525897D0/en
Priority to ARP060105590A priority patent/AR058109A1/en
Priority to PE2006001620A priority patent/PE20071068A1/en
Priority to TW095147457A priority patent/TW200730498A/en
Priority to ES06841477T priority patent/ES2337187T3/en
Priority to EP06841477A priority patent/EP1963307B1/en
Priority to BRPI0620218-7A priority patent/BRPI0620218A2/en
Priority to AU2006328512A priority patent/AU2006328512B2/en
Priority to PT06841477T priority patent/PT1963307E/en
Priority to DE602006010737T priority patent/DE602006010737D1/en
Priority to EP09176715A priority patent/EP2157087A1/en
Priority to PL06841477T priority patent/PL1963307T3/en
Priority to EA200801342A priority patent/EA014354B1/en
Priority to CA002634391A priority patent/CA2634391A1/en
Priority to KR1020087015535A priority patent/KR20080087102A/en
Priority to JP2008546432A priority patent/JP4445570B2/en
Priority to SI200630560T priority patent/SI1963307T1/en
Priority to CNA2006800481062A priority patent/CN101341146A/en
Priority to AT06841477T priority patent/ATE449769T1/en
Priority to DK06841477.0T priority patent/DK1963307T3/en
Priority to US12/158,185 priority patent/US7989629B2/en
Priority to PCT/EP2006/069943 priority patent/WO2007071691A1/en
Priority to IL191967A priority patent/IL191967A0/en
Priority to NO20082695A priority patent/NO20082695L/en
Priority to MA31023A priority patent/MA30373B1/en
Priority to ZA200805299A priority patent/ZA200805299B/en
Priority to CR10102A priority patent/CR10102A/en
Priority to HK09101002.5A priority patent/HK1120265A1/en
Priority to JP2009140796A priority patent/JP2009235087A/en
Priority to CY20101100170T priority patent/CY1110601T1/en
Ceased legal-status Critical Current

Links

GB0525897A 2005-12-20 2005-12-20 Compounds Ceased GB0525897D0 (en)

Priority Applications (30)

Application Number Priority Date Filing Date Title
GB0525897A GB0525897D0 (en) 2005-12-20 2005-12-20 Compounds
ARP060105590A AR058109A1 (en) 2005-12-20 2006-12-18 ACID 3 - (4 - {[4 - (4 - {[3 - (3, 3 - DIMETILE - 1 - PIPERIDINIL) PROPIL] OXI} PHENYL) - 1 - PIPERIDINIL] CARBONIL} - 1 - NAFTALENIL) PROPANOIC AS ANTAGONISTS OF THE RECEIVERS OF HISTAMINE H1 / H3, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE IN THE PREPARATION OF MEDICINES FOR THE TREATMENT
PE2006001620A PE20071068A1 (en) 2005-12-20 2006-12-18 3- (4 - {[4- (4 - {[3- (3,3-DIMETHYL-1-PIPERIDINYL) PROPYL] OXY} PHENYL) -1-PIPERIDINYL] CARBONYL} -1-NAPHTHALENYL) PROPANOIC OR PROPENOIC ACID, SALTS OF THE SAME, AS ANTAGONISTS OF THE H1 AND H3 RECEPTORS
TW095147457A TW200730498A (en) 2005-12-20 2006-12-18 Compounds
PCT/EP2006/069943 WO2007071691A1 (en) 2005-12-20 2006-12-19 3- (4-{ [4-(4-{ [3-(3, 3-dimethyl-1-piperidinyl) propyl] 0xy} phenyl) -1-piperidinyl] carbonyl }-1-naphthalenyl) propanoic or propenoic acid as h1 and h3 receptor antagonists for the treatment of inflammatory and/or allergic disorders
KR1020087015535A KR20080087102A (en) 2005-12-20 2006-12-19 3-(4-{[4-(4-{[3-(3,3)-dimethyl-1-piperidinyl)propyl]oxy}phenyl)-1-piperidinyl]carbonyl}-1-naphthalenyl)propanoic or propenoic acid as h1 and h3 receptor antagonists for the treatment of inflammatory and/or allergic disorders
CNA2006800481062A CN101341146A (en) 2005-12-20 2006-12-19 3- (4- { [4-(4-{ [3-(3, 3-dimethyl-1-piperidinyl) propyl[oxy] phenyl) -1-piperidinyl carbonyl }-1-naphthalenyl) propanoic or propenoic acid as H1 and H3 receptor antagonists for the treatment of infla
BRPI0620218-7A BRPI0620218A2 (en) 2005-12-20 2006-12-19 compound, composition, combination, and use of a compound
AU2006328512A AU2006328512B2 (en) 2005-12-20 2006-12-19 3- (4-{ [4-(4-{ [3-(3, 3-dimethyl-1-piperidinyl) propyl] 0xy} phenyl) -1-piperidinyl] carbonyl }-1-naphthalenyl) propanoic or propenoic acid as H1 and H3 receptor antagonists for the treatment of inflammatory and/or allergic disorders
PT06841477T PT1963307E (en) 2005-12-20 2006-12-19 3- (4- { [4-(4-{ [3-(3, 3-dimethyl-1-piperidinyl) propyl[0xy] phenyl) -1-piperidinyl carbonyl }-1-naphthalenyl) propanoic or propenoic acid as h1 and h3 receptor antagonists for the treatment of inflammatory and/or allergic disorders
DE602006010737T DE602006010737D1 (en) 2005-12-20 2006-12-19 3- (4-äÄ4- (4-Ä3- (3,3-DIMETHYL-1-PIPERIDINYL) PROPYLAOXYÜPHINYLÜ-1-PIPERIDINYLCARBONYLü-1-NAPHTHALINYL) PROPANE OR PROPENIC ACID AS H1 AND H3 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMABLE AND / OR ALLERGIC DISEASES
EP09176715A EP2157087A1 (en) 2005-12-20 2006-12-19 3-(4-{[4-(4-{[3-(3,3-dimethyl-1-piperidinyl)propyl]oxy}phenyl)-1-piperidinyl]carbonyl}-1-naphthalenyl)propanoic or propenoic acid as h1 and h3 receptor antagonists for the treatment of inflammatory and/or allergic disorders
PL06841477T PL1963307T3 (en) 2005-12-20 2006-12-19 3- (4- { [4-(4-{ [3-(3, 3-dimethyl-1-piperidinyl) propyl[0xy] phenyl) -1-piperidinyl carbonyl }-1-naphthalenyl) propanoic or propenoic acid as h1 and h3 receptor antagonists for the treatment of inflammatory and/or allergic disorders
EA200801342A EA014354B1 (en) 2005-12-20 2006-12-19 3-(4-([4-(4-{ [ [3-(3,3dimethyl-1- piperidinyl) propyl] oxy} phenyl)-1-piperidinyl] carbonyl}-1-naphthalenyl)propanoic or propenoic acid as h1 and h3 receptor antagonists for the treatment of inflammatory and/or allergic disorders
CA002634391A CA2634391A1 (en) 2005-12-20 2006-12-19 3- (4-{ ¬4-(4-{ ¬3-(3, 3-dimethyl-1-piperidinyl) propyl| 0xy} phenyl) -1-piperidinyl| carbonyl }-1-naphthalenyl) propanoic or propenoic acid as h1 and h3 receptor antagonists for the treatment of inflammatory and/or allergic disorders
ES06841477T ES2337187T3 (en) 2005-12-20 2006-12-19 ACID 3- (4 - ((4- (4 - ((3- (3,3-DIMETHYL-1-PIPERIDINYL)) PROPIL (OXI) PHENYL) -1-PIPERIDINYL CARBONIL) -1-NAFTALENYL) PROPANOIC OR PROPENOIC AS ANTAGONISTS OF RECEIVER H1 AND H3 FOR THE TREATMENT OF INFLAMMATORY AND / OR ALLERGIC DISORDERS.
JP2008546432A JP4445570B2 (en) 2005-12-20 2006-12-19 3- (4-{[4- (4-{[3- (3,3-Dimethyl-1-piperidinyl) propyl] as H1 and H3 receptor antagonists for treating inflammatory and / or allergic disorders ] Oxy} phenyl) -1-piperidinyl] carbonyl} -1-naphthalenyl) propanoic acid or propenoic acid
SI200630560T SI1963307T1 (en) 2005-12-20 2006-12-19 3- (4- ?í ?á4-(4-?í ?á3-(3, 3-DIMETHYL-1-PIPERIDINYL) PROPYL?á0XY?å PHENYL) -1-PIPERIDINYL CARBONYL ?ç-1-NAPHTHALENYL) PROPANOIC OR PROPENOIC ACID AS H1 AND H3 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY AND/OR ALLERGIC DISORDERS
EP06841477A EP1963307B1 (en) 2005-12-20 2006-12-19 3- (4- { [4-(4-{ [3-(3, 3-dimethyl-1-piperidinyl) propyl[0xy] phenyl) -1-piperidinyl carbonyl }-1-naphthalenyl) propanoic or propenoic acid as h1 and h3 receptor antagonists for the treatment of inflammatory and/or allergic disorders
AT06841477T ATE449769T1 (en) 2005-12-20 2006-12-19 3-(4-ÄÄ4-(4ÄÄ3-(3,3-DIMETHYL-1- PIPERIDINYL)PROPYLÄOXYÜPHINYLÜ-1- PIPERIDINYLCARBONYLÜ-1-NAPHTHALINYL)PROPANE OR PROPENEIC ACID AS H1 AND H3 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY AND/OR ALLERGIC DISEASES
DK06841477.0T DK1963307T3 (en) 2005-12-20 2006-12-19 3- (4 - {[4- (4 - {[3- (3,3-Dimethyl-1-piperidinyl) propyl] oxy} phenyl) -1-piperidinyl] carbonyl} -1-naphthalenyl) propionic or propenoic acid as H1 and H3 receptor antagonists for the treatment of inflammatory and / or allergic disorders
US12/158,185 US7989629B2 (en) 2005-12-20 2006-12-19 3-(4-{ [4-(4-{ [3-(3, 3-dimethyl-1-piperidinyl) propyl] oxy} phenyl)-1-piperidinyl] carbonyl}-1-naphthalenyl) propanoic or propenoic acid as H1 and H3 receptor antagonists for the treatment of inflammatory and/or allergic disorders
IL191967A IL191967A0 (en) 2005-12-20 2008-06-05 3-(4-{[4-(4-{[3-(3,3-dimethyl-1-piperidinyl) propyl]oxy}phenyl)-1-piperidinyl]carbonyl]-1-naphthalenyl)propanoic or propenoic acid as h1 and h3 receptor antagonists for the treatment of inflammatory and/or allergic disorders
NO20082695A NO20082695L (en) 2005-12-20 2008-06-11 3- (4 - {[4- (4 - {[3- (3,3-Dimethyl-1-piperidinyl) propyl] oxy} phenyl) -1-piperidinyl] carbonyl} -1-naphthalenyl) propane or propenoic acid as H1 and H3 receptor antagonists for the treatment of inflammation and / or allergic disorders
MA31023A MA30373B1 (en) 2005-12-20 2008-06-11 3- (4 - {[4- (4 - {[3- (3,3-DIMETHYL-1-PIPERIDINYL) PROPYL] OXY} PHENYL) -1-PIPERIDINYL] CARBONYL} -1-NAPHTHALENYL) PROPANOIC OR PROPENOIC ACIDS IN AS ANTAGONISTS OF H1 AND H3 RECEPTORS FOR THE TREATMENT OF INFLAMMATORY AND / OR ALLERGIC DISORDERS
ZA200805299A ZA200805299B (en) 2005-12-20 2008-06-18 3- (4-{ [4-(4-{[3-(3, 3-dimethyl-1-piperidinyl) propyl] Oxy} phenyl) -1-piperidinyl] carbonyl }-1- naphthalenyl) propanoic or propenoic acid as H1 and H3 receptor antagonists for the treatment of inflammatory and/or allergic disorders
CR10102A CR10102A (en) 2005-12-20 2008-06-20 ACID 3- (4 - {[4- (4 {[3- (3,3, -DIMETIL-1PIPERIDINIL) PROPIL) OXI} PHENYL) 1-PIPERIDINIL] CARBONIL} -1-NAFTALENIL) PROPANOIC OR PROPONEIC AS RECEIVER ANTAGONISTS H1 H3 FOR THE TREATMENT OF INFLAMMATORY AND / OR ALLERGIC DYSFUNCTIONS
HK09101002.5A HK1120265A1 (en) 2005-12-20 2009-02-04 3- (4- {[4-(4-{[3-(3, 3-dimethyl-1-piperidinyl) propyl[0xy] phenyl) -1- piperidinyl carbonyl}-1-naphthalenyl) propanoic or propenoic acid as h1 and h3 receptor antagonists for the treatment of inflammatory and/or allergic disorders
JP2009140796A JP2009235087A (en) 2005-12-20 2009-06-12 3-(4-{[4-(4-{[3-(3,3-dimethyl-1-piperidinyl)propyl]oxy}phenyl)-1-piperidinyl]carbonyl}-1-naphthalenyl)propanoic or propenoic acid as h1 and h3 receptor antagonist for treatment of inflammatory and/or allergic disorder
CY20101100170T CY1110601T1 (en) 2005-12-20 2010-02-19 3- (4 - {[4- (4 - {[3- (3,3-Dimethyl-1-piperidinyl) propyl [oxy] phenyl) -1-piperidinyl] carbonyl} -1-naphthalinyl) propane H1 AND H3 COMPETITORS RECEPTORS FOR TREATMENT OF INFLAMMATORY AND / OR ALLERGIC DISORDERS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0525897A GB0525897D0 (en) 2005-12-20 2005-12-20 Compounds

Publications (1)

Publication Number Publication Date
GB0525897D0 true GB0525897D0 (en) 2006-02-01

Family

ID=35840773

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0525897A Ceased GB0525897D0 (en) 2005-12-20 2005-12-20 Compounds

Country Status (3)

Country Link
CN (1) CN101341146A (en)
GB (1) GB0525897D0 (en)
ZA (1) ZA200805299B (en)

Also Published As

Publication number Publication date
ZA200805299B (en) 2009-10-28
CN101341146A (en) 2009-01-07

Similar Documents

Publication Publication Date Title
GB0508472D0 (en) Compounds
GB0503962D0 (en) Compounds
GB0507602D0 (en) Compounds
GB0502418D0 (en) Compounds
GB0502316D0 (en) Compounds
EP1961741A4 (en) m-CARBAZOLYLPHENYL COMPOUNDS
GB0508463D0 (en) Compounds
GB0502299D0 (en) Compounds
GB0502310D0 (en) Compounds
AP2007004220A0 (en) Motilide compounds
GB0505084D0 (en) Compounds
GB0503961D0 (en) Compounds
EP1907385A4 (en) Compounds
GB0506467D0 (en) Compounds
GB0505086D0 (en) Compounds
GB0508460D0 (en) Compounds
GB0505509D0 (en) Compounds
GB0505735D0 (en) Compounds
GB0501985D0 (en) Compounds
EP1867650A4 (en) Hydroxymethylboron compounds
GB0505085D0 (en) Compounds
GB0501984D0 (en) Compounds
GB0503145D0 (en) Compounds
GB0501839D0 (en) Compounds
GB0500892D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)